Therefore, NIPA1 long alleles do not appear to be more frequent in ALS patients compared with controls (p = 0.392), although we can underline a statistically significant association (OR = 0.1) between REs’ borderline and the clinical phenotype of the disease. The gene discussed is NIPA1; the disease is amyotrophic lateral sclerosis.